Objective: We aimed to develop a transcutaneous bilirubin (TcB) nomogram for assessment of the risk of significant hyperbilirubinemia and prolonged jaundice during the first month of life in term and late-preterm Turkish newborns.
I N T R O D U C T I O N
Transcutaneous bilirubinometers are used to screen for neonatal jaundice [1] . Transcutaneous bilirubin (TcB) measurement has been recommended by the American Academy of Pediatrics as a reasonable alternative to total serum bilirubin for screening newborn infants with jaundice [1, 2] . There are several nomogram studies with various transcutaneous bilirubinometers in the first few days of life [3] [4] [5] [6] . The majority of these TcB nomograms were developed for the first 120 h of age. To our knowledge, there are no published nomograms for Turkish infants beyond 120 h of age, and there is only one study about the course of TcB levels during the first month of life in medical literature [7] .
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Journal of Tropical Pediatrics, 2017, 63, 4-9 doi: 10.1093/tropej/fmw008 Advance Access Publication Date: 7 July 2016 Original paper Draque et al. [8] determined the curve of TcB in breastfed term neonates up to 12 days of life in Brazil. Many newborns are born at home and do not receive any health care within the first few days of life in developing countries such as Turkey. The majority of these newborns admit to hospital after 120 h of age, and thus many cases of early onset jaundice are often missed. Also, there is not any TcB nomogram for the Turkish newborns with prolonged jaundice, admitted to hospital or discharged from hospital after 120 h of age. It is important to understand the behavior of physiological bilirubin values during their hospital stay and after their hospital discharge in a follow-up program. We, thus, aimed to develop a TcB nomogram for assessment of the risk of early significant hyperbilirubinemia and prolonged jaundice thereafter during the first month of life in healthy term and late-preterm Turkish neonates.
M E T H O D S
All term and late-preterm newborns born at the Department of Obstetrics of Gulhane Military Medical Academy between March 1, 2011 and June 1, 2012 were included in the study. Newborns with prematurity (34 weeks), any congenital anomalies and isoimmune hemolytic hyperbilirubinemia were not included in the study. The patients who required treatment for hyperbilirubinemia including phototherapy were not included in the study. The study follows a longitudinal design. All babies born at this institute are regularly followed at the outpatient department of Division of Neonatology on posnatal 3rd, 7th, 15th and 30th days of life. During the study period, demographic characteristics (gender, birth weight, route of delivery, maternal age, gestational age, the rank of child in the family), body weight and TcB level on admission day (3rd, 7th, 15th and 30th days of life), the weight loss on the first admission day as percent in comparison with the birth weight were recorded. Skin measurements were not performed when the patient's condition was assessed as unstable, or when the skin showed signs of lesions at the location of the measurement. The study was conducted according to clinical practice guidelines and approved by the local and national ethics committees. Informed consent was obtained from a parent or guardian of each patient. On the basis of the daily (3rd, 7th, 15th and 30th days) TcB measurements, 3rd, 10th, 25th, 50th, 75th, 90th and 97th percentiles, and 5 percentile tracks were obtained and demonstrated on an age (day) versus TcB graphic (Nomogram). Cutoff TcB levels of the different percentile tracks on the 3rd, 7th, 15th and 30th days were calculated to assess the jaundice risk status of newborns with respect to days (early or prolonged jaundice).
TcB measurements were made by a transcutaneous bilirubinometer (Jaundice Detector JH20-1C [Ningbo David Medical Device Co., Ltd.; Ningbo, China]) as reported in detail elsewhere previously [9] . In our previous study, we have found that the correlation coefficient for Jaundice Detector JH20-1C versus Minolta Air-Shields Jaundice Meter model JM-103 was 0.965 (r ¼ 0.965), the mean difference between the Jaundice Detector JH20-1C versus Minolta Air-Shields Jaundice Meter model JM-103 was 0.26 6 0.95 mg/dl and the Jaundice Detector JH20-1C to have an acceptable level of intradevice imprecision (r ¼ 0.978, p < 0.0001, mean differences 0.0158 6 0.871 mg/dl) [9] . To take a measurement with this transcutaneous bilirubinometer, the probe was positioned on the infant's skin, and three individual scans were taken to produce one measurement that was displayed in mg/dl. If an erroneous measurement is taken, then an error message is displayed, and the scan should be repeated. The TcB measurements were performed on the sternum/ thoracic region. The sternum/thoracic region was not exposed to direct sunlight, and environmental lighting was constant during the study period. ) . Cutoff TcB levels of the different percentile tracks on the 3rd, 7th, 15th and 30th days were given with the lower and upper limits of confidence interval in the second table.
S T A T I S T I C S
R E S U L T S There were a total of 848 newborns initially meeting the entry criteria during the study period. However, 119 newborns were excluded from the study as they completely or partially were lost on follow-up. Demographic characteristics of the newborns are given in Table 1 . The newborns were examined on days 3.3 6 0.9 (2-5), 7.1 6 1.2 (5-12), 15.0 6 2.1 (13-21) and 30.9 6 2.6 (25-45). TcB nomogram of the first month of life obtained from TcB measurements performed on the examination days is given in Fig. 1 . Five percentile tracks are present in this nomogram (Fig. 1) . Cutoff TcB levels of the different (3, 10, 25, 50, 75, 90, 97) percentile tracks on the 3rd, 7th, 15th and 30th days are given in Table 2 . According to these values, cutoff TcB values of the 97th percentile track on the 3rd, 7th, 15th and 30th days (upper limits of the population normals) are 13.0, 13.5, 11.4 and 10.0 mg/dl, respectively (Table 2) .
D I S C U S S I O N
Generally, transcutaneous bilirubinometry is considered a valid screening method for neonatal hyperbilirubinemia, but a confirmatory serum total bilirubin measurement is required when specific therapy for an elevated bilirubin level is being considered [10] . Hour-specific TcB nomograms during the first 72, 96 or 120 h of life have been reported from many countries [6, [11] [12] [13] [14] [15] . In this study, we provided data regarding TcB levels for the first month of life in healthy term and late-preterm Turkish neonates. These data were subsequently used for the development of a day-specific percentile-based TcB nomogram, which represents in fact the natural history of TcB levels up to the 30th day of life. Our nomogram is based on completely normal healthy babies, therefore excluding neonates with any illness potentially increasing hyperbilirubinemia. Because TcB levels generally plateau and then decrease after about 96 h of life in healthy neonates, the first TcB measurement was made on 3rd day of life in the present study. To our knowledge, this is the only study determining the TcB course over the first month of life in Turkish infants and one of only two in the medical literature in any population. Maisels et al. [7] provided the first data on the natural history of bilirubinemia in a population of predominantly breastfed North American, mainly White infants, for the first month after birth. In their study, TcB levels were 5 mg/dl in 43% and 34% of infants on the third and fourth weeks of life, respectively, and these values are very similar to ours (41.98% and 25.9% of infants at age 15.0 6 2.1 days and 30.9 6 2.6 days, respectively). Draque et al. [8] found that TcB values >8.5 mg/dl were still seen in 5% of neonates on day 12 after birth. Tiker et al. [16] found that total serum bilirubin level was >5 mg/dl in 20.2% of the 1 month old, healthy, term infants in southern Turkey. In the present study, TcB levels were 5 mg/dl in 25.9% of infants on day 30.9 6 2.6 of life, which is higher than those reported in the study of Tiker et al [16] ., likely because of our inclusion of term and late-preterm infants.
Neonatal jaundice persisting beyond 14 days of age is a common clinical scenario. Persistent jaundice in the neonate is defined as jaundice that lasts >14-21 days [17] . However, the serum bilirubin level that is considered physiologically normal is not well known and depends mainly on the ethnic and racial distribution of the population and on the type of feeding provided in the first days of life, in addition to other epidemiological factors [8] . It can occur in up to 15% of all newborns, and the vast majority of these neonates have benign unconjugated hyperbilirubinemia, but 1 in 2500 live births has cholestatic liver disease [17] . A total serum bilirubin of 12 mg/dl is usually the level at which further evaluation should be initiated, as hyperbilirubinemia caused by breast milk alone does not usually exceed [18] 12 mg/dl but on occasion does [19] . In the case of an infant with prolonged unconjugated hyperbilirubinemia whose total bilirubin exceeds 12 mg/dl, additional testing should first focus on ruling out hemolysis via hematocrit or hemoglobin, reticulocyte count, direct Coombs' testing and peripheral blood smear [20] . However, the incidence, duration and severity of neonatal jaundice is not equal across all ethnic groups and varies significantly with origin [21, 22] . Furthermore, the genetic basis of the significant ethnic variation in prolonged neonatal jaundice has been demonstrated [23] . Thus, all countries should develop their nomogram by using TcB measurements during the first month of life to avoid over-investigation for prolonged neonatal jaundice. In our study, the 97th percentile of our nomogram on the 7th and 15th days may be useful to differentiate reliably between infants who would and would not require over-investigation for prolonged neonatal jaundice. Tiker et al. [16] have investigated serum bilirubin levels in 1 month old, healthy, term infants from the Adana region in southern Turkey and they suggest that the cutoff level for investigating prolonged jaundice in term, 1 month old, healthy infants in the Turkish population should be >5 mg/dl. The present study does have some limitations. It had a small sample size compared with other reports, and the current nomogram represents data from a single center in Turkey. Further study, a nomogram with a larger sample size from multicenters in Turkey, is needed to overcome these limitations. We have used a second-generation transcutaneous bilirubinometer in the study, and our nomogram could be affected by several variables including the bilirubinometer technology itself. The TcB nomogram we presented in this study can be used in clinical practice to determine the risk status of newborns regarding early significant hyperbilirubinemia in the first days of life or prolonged jaundice thereafter on the basis of TcB measurement in the first month of life. As also a part of normal baby followup in the office-based practice, it should be remembered that 42% and 25.9% of infants have still TcB values of 5 mg/dl at the end of second and fourth weeks of life, respectively, and cutoff TcB values of the 97th percentile track on the 3rd, 7th, 15th and 30th days (upper limits of the population normals) are 13.0, 13.5, 11.4 and 10.0 mg/dl, respectively. In conclusion, our study will provide the basis for developing a national nomogram for screening Turkish infants for jaundice in the first month of life.
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